Does Daily Supplementation of Lactobacillus Acidophilus MPH734, for One Week, Affect Acute (Immediate), Subacute (7 Days), and Post-treatment Discontinuation Lactose Metabolism, Gastrointestinal Symptoms, and Clinical Markers of Inflammation and Safety Compared to a Placebo
Condition: Lactose Intolerance Interventions: Dietary Supplement: Lactobacillus acidophilus MPH734; Dietary Supplement: Placebo Sponsors: Lemuel W. Taylor IV; Manzo Pharmaceuticals Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acidophilus | Diets | Gastroenterology | Lactobacillus Acidophilus | Lactose | Nutrition | Research